Tau protein, the paired helical filament and Alzheimer's disease
about
Multi-Target Directed Donepezil-Like Ligands for Alzheimer's DiseaseAlzheimer's disease pathologic cascades: who comes first, what drives whatMolecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P componentNonhuman primate models of Alzheimer-like cerebral proteopathyPrion-like transmission of protein aggregates in neurodegenerative diseasesImmunological memory to hyperphosphorylated tau in asymptomatic individuals.Synapse assembly and neurodevelopmental disordersAmyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's diseaseThe genetic variation of SORCS1 is associated with late-onset Alzheimer's disease in Chinese Han population.Non-aggregating tau phosphorylation by cyclin-dependent kinase 5 contributes to motor neuron degeneration in spinal muscular atrophy.p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice.Cerebrospinal fluid Aβ42 levels and APP processing pathway genes in Parkinson's disease.Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.Precortical Phase of Alzheimer's Disease (AD)-Related Tau Cytoskeletal PathologyCurcumin: a natural substance with potential efficacy in Alzheimer's disease.Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutationsBrain site-specific proteome changes in aging-related dementia.PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer's diseaseAlzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connectionsTau-induced neurodegeneration: mechanisms and targets.Passive immunization with anti-Tau antibodies in two transgenic models: reduction of Tau pathology and delay of disease progression.Nanotechnology based theranostic approaches in Alzheimer's disease management: Current status and future perspective.Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.Pathological implications of nucleic acid interactions with proteins associated with neurodegenerative diseasesMolecular Pathogenesis of Alzheimer's Disease: An Update.Cardiovascular dementia - a different perspective.Monitoring tau-tubulin interactions utilizing second harmonic generation in living neurons.Human TAUP301L overexpression results in TAU hyperphosphorylation without neurofibrillary tangles in adult zebrafish brainRecent advances in the development of immunotherapies for tauopathiesAltered Regulation of KIAA0566, and Katanin Signaling Expression in the Locus Coeruleus With Neurofibrillary Tangle Pathology.Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser422 containing epitope on pathological tau.Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau
P2860
Q26744105-E7127CF0-2F03-40A4-A1EC-44FD2182D129Q26995896-519DC7EC-50D8-4205-9863-E6EB09AC1614Q27654862-A36E96F3-8B0A-4BA3-A25C-76F836CC9C74Q28728135-C486E08D-CF52-41A0-8749-B0A10A47161DQ33544162-A97CE85C-F48E-4559-96D7-BB858C5FBD39Q33559360-D79085D5-31D4-495B-A362-2E4C34A0E0C4Q34675836-9260792B-BB2D-46F4-9952-241901E59203Q34728911-55C681A4-FFDE-492E-A7D5-C931C0A54B87Q34735117-32B02E43-04D8-4B37-A4AA-4E13B541D90EQ35423634-38CC72A1-D373-4F50-B250-130544E174D9Q35624263-52668884-FCF1-404A-B0CD-8E68FA99EE44Q35772659-5A5DB79A-AFB5-4A86-9F3D-E19520F427A8Q36136387-86DB0AD3-3ABC-4B96-B8DF-9598CDA85F8AQ36484091-2F4507C2-7FE0-4A7D-8F3C-FC210DFA2FB4Q36891064-3152B5F4-0353-4B58-8FBC-3AAC0CEE25C4Q37010838-1CCCAAEF-7EA3-4B63-BBEC-635077EF74B9Q37212178-A7505FD5-BAA7-4476-B654-3CED077B8E50Q37310632-37C7A1E4-C8A0-4368-8813-85599F3A08ADQ38014513-90C2D88D-FA23-4744-9DC7-D2FACEC75596Q38204720-5113E9A7-A28A-47B2-84B2-11FD14E78224Q38674158-F1F340D2-9040-4CB5-8099-0785085E195AQ38686370-FF30BFC6-0A1D-4063-AA40-E6A46D477F50Q38942540-7DF1C3F9-8883-44A0-88E5-556C19D05485Q39310077-41B7160E-C611-4882-B075-4F4B37F64C85Q39355183-462B5810-0F58-4E50-ACA5-450122B0E353Q40361355-D3466CFF-317F-4AA5-AA29-C70C243B3C7AQ41224334-CAA07CB5-07C0-4925-A001-44382E4A0E90Q42374946-D1F68A1A-4CB5-4653-923C-11C2A8B8B1BCQ42778736-73D7F4F9-6468-4AC9-B826-BA3B5D7655DAQ55172664-EDF989C7-3F1B-4578-AE71-4DFC6F50BE22Q55663766-AFAB776B-A0DF-4287-924D-AE2261B70ACFQ58708935-74D5F7B6-5EBF-4E82-93AB-35A103CB9D8C
P2860
Tau protein, the paired helical filament and Alzheimer's disease
description
2006 nî lūn-bûn
@nan
2006 թուականին հրատարակուած գիտական յօդուած
@hyw
2006 թվականին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Tau protein, the paired helical filament and Alzheimer's disease
@ast
Tau protein, the paired helical filament and Alzheimer's disease
@en
Tau protein, the paired helical filament and Alzheimer's disease
@nl
type
label
Tau protein, the paired helical filament and Alzheimer's disease
@ast
Tau protein, the paired helical filament and Alzheimer's disease
@en
Tau protein, the paired helical filament and Alzheimer's disease
@nl
prefLabel
Tau protein, the paired helical filament and Alzheimer's disease
@ast
Tau protein, the paired helical filament and Alzheimer's disease
@en
Tau protein, the paired helical filament and Alzheimer's disease
@nl
P2093
P3181
P1476
Tau protein, the paired helical filament and Alzheimer's disease
@en
P2093
Aaron Klug
Michel Goedert
R Anthony Crowther
P304
P3181
P407
P433
P577
2006-01-01T00:00:00Z